Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

Journal of the Neurological Sciences

Volumn 306, Issue 1-2, 2011, Pages 82-90

  Jarius, S ^a   Paul, F ^b   Franciotta, D ^c   Ruprecht, K ^b   Ringelstein, M ^d   Bergamaschi, R ^c   Rommer, P ^e   Kleiter, I ^f   Stich, O ^g   Reuss, R ^h   Rauer, S ^g   Zettl, U K ⁱ   Wandinger, K P ^j,k   Melms, A ^l   Aktas, O ^d   Kristoferitsch, W ^m   Wildemann, B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f Regensburg University Medical Centre   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h Hospital Hohe Warte   (Germany)

ⁱ UNIVERSITY OF ROSTOCK   (Germany)

^j Institute of Experimental Immunology   (Germany)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l UNIVERSITY OF TÜBINGEN   (Germany)

^m DANUBE HOSPITAL   (Austria)

more..

Author keywords

Albumin; Antibody to aquaporin 4; Cerebrospinal fluid; IgG, IgM, IgA; Lactate; Longitudinally extensive transverse myelitis; Lumbar puncture; Neuromyelitis optica (Devic disease); NMO IgG; Oligoclonal bands; Recurrent optic neuritis; Total protein

Indexed keywords

ALBUMIN; AQUAPORIN 4; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTIC ACID; PROTEIN;

ADOLESCENT; ADULT; AGED; BIOCHEMISTRY; CAUCASIAN; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; CYTOGENETICS; DISEASE ACTIVITY; EOSINOPHIL; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUTROPHIL; OPTIC NEURITIS; PLASMA CELL; PLEOCYTOSIS; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ALBUMINS; ANTIBODIES; AQUAPORIN 4; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; LACTIC ACID; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; OLIGOCLONAL BANDS; SERUM ALBUMIN; SPINAL PUNCTURE; YOUNG ADULT;

EID: 79958765901     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.03.038     Document Type: Conference Paper

References (45)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14. (Pubitemid 29442132)
2. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007;68:1076-7. (Pubitemid 46569147)
3. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4water channel. J Exp Med 2005;202:473-7. (Pubitemid 41186945)
4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12. (Pubitemid 39626806)
5. Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 2007;4:e133.
6. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008;4:202-14. (Pubitemid 351516748)
7. Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010;6:383-92.
8. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009;66:630-43.
9. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009;66:617-29.
10. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009;386:623-7.
11. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, et al. Antiaquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun 2010;394:205-10.
12. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010;133(Pt2):349-61.
13. Bergamaschi R. Importance of cerebrospinal fluid examination in differential diagnosis of Devic's neuromyelitis optica by multiple sclerosis. Neurol Sci 2003;24:95-6. (Pubitemid 37304275)
14. Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, Tavazzi E, Piccolo G, et al. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 2004;10:2-4. (Pubitemid 38100519)
15. Piccolo G, Franciotta DM, Camana C, Bergamaschi R, Banfi P, Sandrini G, et al. Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases. J Neurol 1990;237:262-4. (Pubitemid 20213313)
16. Zaffaroni M. Cerebrospinal fluid findings in Devic's neuromyelitis optica. Neurol Sci 2004;25(Suppl 4):S368-70.
17. Nakamura M, Nakashima I, Sato S, Miyazawa I, Fujihara K, Itoyama Y. Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands. Mult Scler 2007;13:332-5. (Pubitemid 46705993)
18. Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, et al. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 2010;7:52.
19. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9. (Pubitemid 43958540)
20. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006;59:566-9. (Pubitemid 43358081)
21. Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 2010;291:52-6.
22. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994;57:897-902. (Pubitemid 24251050)
23. Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998;4:99-107. (Pubitemid 28410032)
24. Reiber H. Flow rate of cerebrospinal fluid (CSF)-a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994;122:189-203. (Pubitemid 24097269)
25. Reiber H, Teut M, Pohl D, Rostasy KM, Hanefeld F. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Mult Scler 2009;15:1466-80.
26. Franciotta D, Jarius S, Aloisi F. More on multiple sclerosis and neuromyelitis optica. Arch Neurol 2007;64:1802 author reply-3.
27. Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 2007;64:899-901. (Pubitemid 46919849)
28. Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis. Arch Neurol 2007;64:901-3. (Pubitemid 46919850)
29. Roach ES. Is neuromyelitis optica a distinct entity? Arch Neurol 2007;64:906.
30. Walsh MJ, Tourtellotte WW. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med 1986;163:41-53. (Pubitemid 16189509)
31. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, et al. Antiaquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007;130:1235-43. (Pubitemid 47355956)
32. Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL, et al. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol 2010;67:1201-8.
33. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995;99:153-63.
34. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine Baltimore 2004;83:280-91. (Pubitemid 39258414)
35. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-61. (Pubitemid 34755161)
36. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-9. (Pubitemid 352008474)
37. Jarius S, Franciotta D, Bergamaschi R, Wildemann B, Wandinger KP. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Clin Chem Lab Med 2010;48:659-63.
38. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008;131:3072-80.
39. Jongen PJ, Lamers KJ, Doesburg WH, Lemmens WA, Hommes OR. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:446-51. (Pubitemid 27423549)
40. Posner JB, Plum F. Independence of blood and cerebrospinal fluid lactate. Arch Neurol 1967;16:492-6.
41. Kleine TO, Baerlocher K, Niederer V, Keller H, Reutter F, Tritschler W, et al. Diagnostic significance of lactate concentration in CSF in patients with meningitis (author's transl). Dtsch Med Wochenschr 1979;104:553-7. (Pubitemid 9150498)
42. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162-8. (Pubitemid 23223043)
43. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002;197:57-61. (Pubitemid 34462145)
44. Collongues N, Marignier R, Zephir H, Papeix C, Blanc F, Ritleng C, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 2010;74:736-42.
45. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 2004;63:2363-70. (Pubitemid 40024351)